Beximco Pharmaceuticals, a company that manufactures and sells generic pharmaceutical formulation products, active pharmaceutical ingredients and intravenous fluids and also manufactures and markets its own branded generics for almost all diseases, has reported revenues of $1.3m for the first quarter ended Mar 31, 2010, compared to $1.08m for the comparable period in 2009.
Beximco Pharma has posted a net profit of $0.21m for the first quarter 2010, or $1.3 earnings per share (EPS), compared to $0.12m, or $0.82 EPS, for the comparable period in 2009. Profit from operations was $0.33m, compared to $.22m for the comparable period in 2009.
Beximco Pharma has reported gross profit of $0.63m for the first quarter 2010, compared to $0.52m for the same period last year.
Beximco Pharma also undertakes contract manufacturing for multinational pharmaceutical companies. It operates from a 20 acre site in Dhaka and currently employs over 2,400 staff.